Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Surgery Today
Published in: Surgery Today 2/2018

01-02-2018 | Original Article

Long-term outcomes of laparoscopic versus open splenectomy for immune thrombocytopenia

Authors: Kazuhiro Tada, Masayuki Ohta, Kunihiro Saga, Hiroomi Takayama, Teijiro Hirashita, Yuichi Endo, Hiroki Uchida, Yukio Iwashita, Masafumi Inomata

Published in: Surgery Today | Issue 2/2018

Login to get access

Abstract

Purpose

Splenectomy is the standard therapy for medically refractory immune thrombocytopenia (ITP). Laparoscopic splenectomy (LS) has gained wide acceptance; however, the long-term outcomes of LS versus open splenectomy (OS) for patients with ITP remain unclear.

Methods

We analyzed, retrospectively, 32 patients who underwent splenectomy, as LS in 22 and OS in 10, for refractory ITP at our institute. Data were evaluated based on the American Society of Hematology 2011 evidence-based practice guidelines for ITP.

Results

Although the operation time was significantly longer in the LS group (p < 0.01), LS was associated with less blood loss (p < 0.01), infrequent blood transfusion during surgery (p < 0.01), quicker resumption of oral intake (p < 0.01), and shorter hospital stay (p < 0.01) than OS. Positive responses, including complete and partial remission, were achieved in 90% of the OS group patients and 77% of the LS group patients. The mean follow-up periods were 183 and 92 months, respectively. Relapse-free survival rates, 15 years after the operation were 63% in the OS group and 94% in the LS group.

Conclusions

LS can provide better short-term results and comparable long-term results to those of OS for ITP.
Literature
1.
Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113:2386–93.CrossRefPubMed
2.
Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168–86.CrossRefPubMed
3.
Chater C, Terriou L, Duhamel A, Launay D, Chambon JP, Pruvot FR, et al. Reemergence of splenectomy for ITP second-line treatment? Ann Surg. 2016;264:772–7.CrossRefPubMed
4.
Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004;104:2623–34.CrossRefPubMed
5.
Vianelli N, Galli M, de Vivo A, Intermesoli T, Giannini B, Mazzucconi MG, et al. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases. Haematologica. 2005;90:72–7.PubMed
6.
Lefor AT, Melvin WS, Bailey RW, Flowers JL. Laparoscopic splenectomy in the management of immune thrombocytopenia purpura. Surgery. 1993;114:613–8.PubMed
7.
Gigot JF, Healy ML, Ferrant A, Michaux JL, Njinou B, Kestens PJ. Laparoscopic splenectomy for idiopathic thrombocytopenic purpura. Br J Surg. 1994;81:1171–2.CrossRefPubMed
8.
Hashizume M, Sugimachi K, Kitano S, Shimada M, Baba H, Ueno K, et al. Laparoscopic splenectomy. Am J Surg. 1994;167:611–4.CrossRefPubMed
9.
Watson DI, Coventry BJ, Chin T, Gill PG, Malycha P. Laparoscopic versus open splenectomy for immune thrombocytopenic purpura. Surgery. 1997;121:18–22.CrossRefPubMed
10.
Lozano-Salazar RR, Herrera MF, Vargas-Vorackova F, Lopez-Karpovitch X. Laparoscopic versus open splenectomy for immune thrombocytopenic purpura. Am J Surg. 1998;176:366–9.CrossRefPubMed
11.
Tanoue K, Hashizume M, Morita M, Migoh S, Tsugawa K, Yagi S, et al. Results of laparoscopic splenectomy for immune thrombocytopenic purpura. Am J Surg. 1999;177:222–6.CrossRefPubMed
12.
Winslow ER, Brunt LM. Perioperative outcomes of laparoscopic versus open splenectomy: a meta-analysis with an emphasis on complications. Surgery. 2003;134:647–53 (discussion 54–5).CrossRefPubMed
13.
Friedman RL, Fallas MJ, Carroll BJ, Hiatt JR, Phillips EH. Laparoscopic splenectomy for ITP. The gold standard. Surg Endosc. 1996;10:991–5.CrossRefPubMed
14.
Sampath S, Meneghetti AT, MacFarlane JK, Nguyen NH, Benny WB, Panton ON. An 18-year review of open and laparoscopic splenectomy for idiopathic thrombocytopenic purpura. Am J Surg. 2007;193:580–3 (discussion 3–4).CrossRefPubMed
15.
Wu JM, Lai IR, Yuan RH, Yu SC. Laparoscopic splenectomy for idiopathic thrombocytopenic purpura. Am J Surg. 2004;187:720–3.CrossRefPubMed
16.
Qu Y, Xu J, Jiao C, Cheng Z, Ren S. Long-term outcomes of laparoscopic splenectomy versus open splenectomy for idiopathic thrombocytopenic purpura. Int Surg. 2014;99:286–90.CrossRefPubMedPubMedCentral
17.
Vecchio R, Marchese S, Intagliata E, Swehli E, Ferla F, Cacciola E. Long-term results after splenectomy in adult idiopathic thrombocytopenic purpura: comparison between open and laparoscopic procedures. J Laparoendosc Adv Surg Tech A. 2013;23:192–8.CrossRefPubMed
18.
Rijcken E, Mees ST, Bisping G, Krueger K, Bruewer M, Senninger N, et al. Laparoscopic splenectomy for medically refractory immune thrombocytopenia (ITP): a retrospective cohort study on longtime response predicting factors based on consensus criteria. Int J Surg. 2014;12:1428–33.CrossRefPubMed
19.
Xu T, Li N, Jin F, Wu K, Ye Z. Predictive factors of idiopathic thrombocytopenic purpura and long-term survival in Chinese adults undergoing laparoscopic splenectomy. Surg Laparosc Endosc Percutan Tech. 2016;26:397–400.CrossRefPubMed
20.
Ohta M, Nishizaki T, Matsumoto T, Shimabukuro R, Sasaki A, Shibata K, et al. Analysis of risk factors for massive intraoperative bleeding during laparoscopic splenectomy. J Hepatobiliary Pancreat Surg. 2005;12:433–7.CrossRefPubMed
21.
Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117:4190–207.CrossRefPubMed
22.
Tsiotos G, Schlinkert RT. Laparoscopic splenectomy for immune thrombocytopenic purpura. Arch Surg. 1997;132:642–6.CrossRefPubMed
23.
Duperier T, Brody F, Felsher J, Walsh RM, Rosen M, Ponsky J. Predictive factors for successful laparoscopic splenectomy in patients with immune thrombocytopenic purpura. Arch Surg. 2004;139:61–6.CrossRefPubMed
24.
Mikhael J, Northridge K, Lindquist K, Kessler C, Deuson R, Danese M. Short-term and long-term failure of laparoscopic splenectomy in adult immune thrombocytopenic purpura patients: a systematic review. Am J Hematol. 2009;84:743–8.CrossRefPubMed
25.
Chang M, Nakagawa PA, Williams SA, Schwartz MR, Imfeld KL, Buzby JS, et al. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood. 2003;102:887–95.CrossRefPubMed
26.
McMillan R, Wang L, Tomer A, Nichol J, Pistillo J. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood. 2004;103:1364–9.CrossRefPubMed
27.
Koshenkov VP, Pahuja AK, Nemeth ZH, Abkin A, Carter MS. Identification of accessory spleens during laparoscopic splenectomy is superior to preoperative computed tomography for detection of accessory spleens. JSLS. 2012;16:387–91.CrossRefPubMedPubMedCentral
28.
Budzynski A, Bobrzynski A, Sacha T, Skotnicki A. Laparoscopic removal of retroperitoneal accessory spleen in patient with relapsing idiopathic thrombocytopenic purpura 30 years after classical splenectomy. Surg Endosc. 2002;16:1636.CrossRefPubMed
29.
Napoli A, Catalano C, Silecchia G, Fabiano P, Fraioli F, Pediconi F, et al. Laparoscopic splenectomy: multi-detector row CT for preoperative evaluation. Radiology. 2004;232:361–7.CrossRefPubMed
30.
Quah C, Ayiomamitis GD, Shah A, Ammori BJ. Computed tomography to detect accessory spleens before laparoscopic splenectomy: is it necessary? Surg Endosc. 2011;25:261–5.CrossRefPubMed
31.
Habermalz B, Sauerland S, Decker G, Delaitre B, Gigot JF, Leandros E, et al. Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc. 2008;22:821–48.CrossRefPubMed
32.
Imbach P, Barandun S, d’Apuzzo V, Baumgartner C, Hirt A, Morell A, et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet. 1981;1:1228–31.CrossRefPubMed
33.
Bussel JB. The use of intravenous gamma-globulin in idiopathic thrombocytopenic purpura. Clin Immunol Immunopathol. 1989;53:S147–55.CrossRefPubMed
34.
Imbach P, Wagner HP, Berchtold W, Gaedicke G, Hirt A, Joller P, et al. Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet. 1985;2:464–8.CrossRefPubMed
35.
Fehr J, Hofmann V, Kappeler U. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. N Engl J Med. 1982;306:1254–8.CrossRefPubMed
36.
Bussel JB, Kimberly RP, Inman RD, Schulman I, Cunningham-Rundles C, Cheung N, et al. Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura. Blood. 1983;62:480–6.PubMed
37.
Abe T, Matsuda J, Kawasugi K, Yoshimura Y, Kinoshita T, Kazama M. Clinical effect of intravenous immunoglobulin on chronic idiopathic thrombocytopenic purpura. Blut. 1983;47:69–75.CrossRefPubMed
38.
Hamabe A, Omori T, Oyama T, Akamatsu H, Yoshidome K, Tori M, et al. A case of Helicobacter pylori infection complicated with gastric cancer, gastric mucosa-associated lymphoid tissue lymphoma, and idiopathic thrombocytopenic purpura successfully treated with laparoscopy-assisted total gastrectomy and splenectomy. Asian J Endosc Surg. 2011;4:32–5.CrossRefPubMed
39.
Suzuki T, Matsushima M, Masui A, Watanabe K, Takagi A, Ogawa Y, et al. Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura—a randomized controlled trial. Am J Gastroenterol. 2005;100:1265–70.CrossRefPubMed
40.
Fujimura K, Kuwana M, Kurata Y, Imamura M, Harada H, Sakamaki H, et al. Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan. Int J Hematol. 2005;81:162–8.CrossRefPubMed
41.
Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C, et al. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med. 2007;146:25–33.CrossRefPubMed
42.
Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet. 2008;371:395–403.CrossRefPubMed
43.
Bussel JB, Cheng G, Saleh MN, Psaila B, Kovaleva L, Meddeb B, et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med. 2007;357:2237–47.CrossRefPubMed
44.
Palandri F, Polverelli N, Catani L, Sollazzo D, Romano M, Levorato M, et al. The choice of second-line therapy in steroid-resistant immune thrombocytopenia: role of platelet kinetics in a single-centre long-term study. Am J Hematol. 2014;89:1047–50.CrossRefPubMed
45.
Ghanima W, Godeau B, Cines DB, Bussel JB. How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. Blood. 2012;120:960–9.CrossRefPubMed
Metadata
Title
Long-term outcomes of laparoscopic versus open splenectomy for immune thrombocytopenia
Authors
Kazuhiro Tada
Masayuki Ohta
Kunihiro Saga
Hiroomi Takayama
Teijiro Hirashita
Yuichi Endo
Hiroki Uchida
Yukio Iwashita
Masafumi Inomata
Publication date
01-02-2018
Publisher
Springer Japan
Published in
Surgery Today / Issue 2/2018
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-017-1570-2

Other articles of this Issue 2/2018

Surgery Today 2/2018 Go to the issue

Original Article

Serum calcitonin reference values for calcium stimulation tests by electrochemiluminescence immunoassay in Japanese men with non-medullary thyroid carcinoma

Original Article

The prognostic impact of combined pulmonary fibrosis and emphysema in patients with clinical stage IA non-small cell lung cancer

Original Article

Evaluating vertebral artery dominancy before T4 lung cancer surgery requiring subclavian artery reconstruction

Original Article

New classification for the thoracic paraaortic lymph nodes of patients with esophageal squamous cell carcinoma

Review Article

Preoperative imaging evaluation of pancreatic pathologies for the objective prediction of pancreatic fistula after pancreaticoduodenectomy

Original Article

Efficacy of the traditional Japanese medicine goreisan for the resolution of spermatic cord hydrocele in children